Colgate-Palmolive (CL) stock
NYSE
As of the Nov 13, 2026 close (U.S. Eastern)
- Market cap
- $79.2B
- As of Nov 13, 2026
- P/E
- 38.58x
- Trailing twelve months
- P/B
- 275.13x
- Latest reported equity
- P/S
- 3.72x
- Trailing twelve months
- ROE
- 713.2%
- Trailing twelve months
- Dividend yield
- 2.09%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
- Market cap
- $79.2B
- As of Nov 13, 2026
- P/E
- 38.58x
- Trailing twelve months
- P/B
- 275.13x
- Latest reported equity
- P/S
- 3.72x
- Trailing twelve months
- ROE
- 713.2%
- Trailing twelve months
- Dividend yield
- 2.09%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
38.58x
P/B
275.13x
P/S
3.72x
Earnings and dividend metrics▾
Earnings
EPS
$2.58
Earnings per share
BPS
$0.36
Book value per share
ROE
713.2%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $2.58 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $0.36 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 713.2%.
Dividends
Yield
2.09%
Dividend per share
$2.08
Payout ratio
88.8%
Consecutive years
9+ yrs
Yield uses fiscal 2025 dividends · Dividend per share and payout ratio are for fiscal 2025.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $208.00 before tax.
- Payout ratio — 88.8% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 9 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 4.6% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $5.13B+4.6%
$5.03B
Jul–Sep '24
$5.13B
Jul–Sep '25
$5.37B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 30, 2026.
- Earnings per share increased 3.3% from the same quarter a year earlier.
- Revenue increased 4.6% from the same quarter a year earlier.
- Operating income increased 2.7% from the same quarter a year earlier.
- Net income increased 2.2% from the same quarter a year earlier.
Filed Oct 30, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Malcolm GregoryEVP and Controller · Nov 10, 2026Open-market sale4,100 shares · $402KAvg. price $97.9710,061 shares held after
- Wallace Noel R.Chairman, President & CEO · Nov 5, 2026Open-market sale20,000 shares · $2.0MAvg. price $100.2581359,700 shares held after
- NORRINGTON LORRIE MDirector · Nov 5, 2026Open-market sale4,170 shares · $414KAvg. price $99.310143,383 shares held after
- NORRINGTON LORRIE MDirector · Nov 5, 2026Option exercise4,170 shares · $298KAvg. price $71.5647,553 shares held after
- Hazlin JohnChief Growth Officer · Nov 4, 2026Open-market sale23,376 shares · $2.3MAvg. price $99.147927,021 shares held after
- Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin · Nov 4, 2026Open-market sale19,938 shares · $2.0MAvg. price $98.74159,111 shares held after
- Hazlin JohnChief Growth Officer · Nov 4, 2026Option exercise23,376 shares · $1.8MAvg. price $77.0450,397 shares held after
- Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin · Nov 4, 2026Option exercise19,938 shares · $1.5MAvg. price $76.4129,049 shares held after
- NORRINGTON LORRIE MDirector · Oct 1, 2026Grant or award300 shares · $26KAvg. price $87.4243,310 shares held after
- BILBREY JOHN PDirector · Oct 1, 2026Grant or award271 shares · $24KAvg. price $87.4240,725 shares held after
- Newman BrianDirector · Oct 1, 2026Grant or award214 shares · $19KAvg. price $87.428,058 shares held after
- GRANT SHANECOO, Americas · Sep 16, 2026Grant or award7,355 shares · $0Avg. price $079,503 shares held after
- SUTULA STANLEY J IIIChief Financial Officer · Sep 16, 2026Grant or award8,045 shares · $0Avg. price $079,029 shares held after
- Malcolm GregoryEVP and Controller · Sep 16, 2026Grant or award1,081 shares · $0Avg. price $014,162 shares held after
- Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin · Sep 16, 2026Grant or award4,597 shares · $0Avg. price $011,447 shares held after
- Massey SallyChief People Officer · Sep 16, 2026Grant or award3,333 shares · $0Avg. price $015,397 shares held after
- Wallace Noel R.Chairman, President & CEO · Sep 16, 2026Grant or award29,649 shares · $0Avg. price $0379,700 shares held after
- Hazlin JohnChief Growth Officer · Sep 16, 2026Grant or award3,908 shares · $0Avg. price $027,021 shares held after
- Fishbone BetsyCLO and Secretary · Sep 16, 2026Grant or award2,207 shares · $0Avg. price $016,050 shares held after
- Wallace Noel R.Chairman, President & CEO · Sep 13, 2026Shares withheld for taxes4,892 shares · $425KAvg. price $86.8350,051 shares held after
- SUTULA STANLEY J IIIChief Financial Officer · Sep 13, 2026Shares withheld for taxes1,385 shares · $120KAvg. price $86.870,984 shares held after
- Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin · Sep 13, 2026Shares withheld for taxes922 shares · $80KAvg. price $86.86,850 shares held after
- Massey SallyChief People Officer · Sep 13, 2026Shares withheld for taxes686 shares · $60KAvg. price $86.812,064 shares held after
- Hazlin JohnChief Growth Officer · Sep 13, 2026Shares withheld for taxes499 shares · $43KAvg. price $86.823,113 shares held after
- Fishbone BetsyCLO and Secretary · Sep 13, 2026Shares withheld for taxes472 shares · $41KAvg. price $86.813,843 shares held after
- Malcolm GregoryEVP and Controller · Sep 13, 2026Shares withheld for taxes225 shares · $20KAvg. price $86.813,081 shares held after
- Wallace Noel R.Chairman, President & CEO · Sep 12, 2026Shares withheld for taxes3,516 shares · $305KAvg. price $86.8354,943 shares held after
- SUTULA STANLEY J IIIChief Financial Officer · Sep 12, 2026Shares withheld for taxes927 shares · $80KAvg. price $86.872,369 shares held after
- Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin · Sep 12, 2026Shares withheld for taxes618 shares · $54KAvg. price $86.87,772 shares held after
- Massey SallyChief People Officer · Sep 12, 2026Shares withheld for taxes459 shares · $40KAvg. price $86.812,750 shares held after
- Hazlin JohnChief Growth Officer · Sep 12, 2026Shares withheld for taxes439 shares · $38KAvg. price $86.823,612 shares held after
- Fishbone BetsyCLO and Secretary · Sep 12, 2026Shares withheld for taxes331 shares · $29KAvg. price $86.814,315 shares held after
- Malcolm GregoryEVP and Controller · Sep 12, 2026Shares withheld for taxes151 shares · $13KAvg. price $86.813,306 shares held after
- Wallace Noel R.Chairman, President & CEO · Sep 11, 2026Shares withheld for taxes4,071 shares · $353KAvg. price $86.8358,459 shares held after
- SUTULA STANLEY J IIIChief Financial Officer · Sep 11, 2026Shares withheld for taxes1,197 shares · $104KAvg. price $86.873,296 shares held after
- Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin · Sep 11, 2026Shares withheld for taxes684 shares · $59KAvg. price $86.88,390 shares held after
- Massey SallyChief People Officer · Sep 11, 2026Shares withheld for taxes651 shares · $57KAvg. price $86.813,209 shares held after
- Hazlin JohnChief Growth Officer · Sep 11, 2026Shares withheld for taxes649 shares · $56KAvg. price $86.824,051 shares held after
- GRANT SHANECOO, Americas · Sep 11, 2026Shares withheld for taxes622 shares · $54KAvg. price $86.872,148 shares held after
- Fishbone BetsyCLO and Secretary · Sep 11, 2026Shares withheld for taxes404 shares · $35KAvg. price $86.814,646 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary8-KThe company said net sales for Q3 rose 4.6% to $5,369 million, and organic sales grew 3.6%. Organic sales include a 0.2% negative impact from lower private label pet food sales.Published Oct 30, 2026 · Filed Oct 30, 2026Read the summary →
- AI summary8-KThe company said full-year 2025 net sales rose 1.4% to $20,382 million, and GAAP diluted EPS fell 25% to $2.63. Base Business EPS increased 3% to $3.69.Published Oct 2, 2026 · Filed Jan 30, 2026Read the summary →
- AI summary8-KColgate-Palmolive said on November 3, 2025 it executed an underwriting agreement with Barclays Bank PLC and Banco Bilbao Vizcaya Argentaria, S.A., as representatives of the underwriters, to issue and sell €600,000,000 aggregate principal amount of 3.250% Senior Notes due 2035.Published Oct 12, 2026 · Filed Nov 10, 2025Read the summary →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Colgate-Palmolive (CL) stock information
NYSE
Colgate-Palmolive (CL) is listed on NYSE. Its market capitalization is about $79.2B. On trailing-twelve-month earnings the P/E ratio is 38.58, and the P/B ratio is 275.13. Return on equity is 713.2%. These figures are computed in-house from official filings and are reference information only.
Colgate-Palmolive — frequently asked questions
- What is the P/E ratio of Colgate-Palmolive (CL)?
- On a trailing-twelve-month basis, CL trades at a P/E ratio of 38.58. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Colgate-Palmolive?
- CL has a market capitalization of about $79.2B. The figure moves with the share price and is refreshed each trading day.
- Does Colgate-Palmolive pay a dividend?
- CL has a dividend yield of about 2.09%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.